Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

NorthStar Commended by Frost & Sullivan for its RadioGenix® System, An Innovative High-Tech Separation Platform for Processing Non-Uranium-based Mo-99 - The RadioGenix® System addresses molybdenum-99 (Mo-99) availability, nuclear proliferation, and environmental concerns to drive the U.S. medical radioisotope industry - NorthStarNM.com / Frost.com
NorthStar Commended by Frost & Sullivan for its RadioGenix® System, An Innovative High-Tech Separation Platform for Processing Non-Uranium-based Mo-99

 

PRZOOM - /newswire/ - Santa Clara, CA, United States, 2020/10/29 - The RadioGenix® System addresses molybdenum-99 (Mo-99) availability, nuclear proliferation, and environmental concerns to drive the U.S. medical radioisotope industry - NorthStarNM.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the North American nuclear medicine imaging market, Frost & Sullivan recognizes NorthStar Medical Radioisotopes, LLC (NorthStar) with the 2020 North American Enabling Technology Leadership Award. The company’s RadioGenix® System is an innovative, high tech radioisotope separation platform for use in producing medically important technetium-99m (Tc-99m) from non-uranium produced molybdenum-99 (Mo-99). Vertically integrated NorthStar will ensure reliable U.S. supply of Mo-99/Tc-99m with long-term predictable pricing for essential diagnostic imaging studies while eliminating harmful radioactive waste.

“The first-of-its-kind RadioGenix System is a flexible, high-tech separation platform for processing non-uranium/based Mo-99. The system leverages two production routes using naturally occurring molybdenum as a starting material,” said Dr. Suresh Kuppuswamy, Industry Principal. “In the neutron capture process, a neutron is added to the Mo-98 isotope, which comprises about 24% of natural molybdenum, to produce Mo-99. In the very near future, NorthStar will irradiate a concentrated form of molybdenum, (cMo-98) (greater than 95% Mo-98) to improve production by a factor of four. NorthStar’s neutron ‘knock-out’ process complements neutron capture technology and relies on high-power electron accelerators to knock out a neutron from the Mo-100 isotope to produce Mo-99.”

As the first domestic supplier and the only vertically integrated company, NorthStar streamlines the Mo-99 supply chain, mitigates risks along the process, and minimizes disruptions to the healthcare system. NorthStar’s production processes are environmentally friendly in contrast to uranium-based processes that generate a vast amount of long half-life radioactive waste. The company’s intellectual property includes patented non-uranium-based Mo-99 domestic production methods, separation chemistry and sterilization systems, and an expandable technology platform with solutions in both diagnostics and therapeutics.

NorthStar (northstarnm.com) aims to use both neutron capture Mo-99 produced at the University of Missouri Research Reactor (MURR®) and neutron knock-out Mo-99 produced in Beloit, Wisconsin to ensure dual production hubs and therefore highly reliable domestic supply. The company adds liquid Mo-99 solution into tungsten-shielded source vessels and ships them to radiopharmacies across the United States. With a RadioGenix System installed on-site, a Nuclear Pharmacist places the Mo-99 source vessel in the system. The RadioGenix System then extracts the Tc-99 from the Mo-99 and delivers the critical medical radioisotope in a vial ready to use for compounding patient doses.

“NorthStar’s end-to-end solution, both as Mo-99 supplier and Tc-99m generator manufacturer, truly revolutionizes the U.S. medical radioisotope industry,” noted Dr. Suresh. “NorthStar is prioritizing its isotope pipeline to meet evolving market demand, and is currently working on actinium-225 and copper-67 for therapeutic applications. With the RadioGenix System, NorthStar is exceptionally well-positioned to capitalize on emerging needs and opportunities while supporting nuclear medicine’s evolving role in value-based care.”

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that enhances current products and enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
For over five decades, Frost & Sullivan (frost.com) has become world renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


NorthStar Commended by Frost & Sullivan for its RadioGenix® System, An Innovative High-Tech Separation Platform for Processing Non-Uranium-based Mo-99

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Medical Radioisotopes | Frost & Sullivan
Contact: Kristen Moore - Frost.com 
210-247-3823 kristen.moore[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services / Equipment Most Recent Related Press Releases:

Imec Signs Licensing Agreement with miDiagnostics to Commercialize its Patented Technology for Fast and Reliable COVID-19 Diagnosis
Withings Announces the FDA Clearance of ScanWatch its Most Medically Advanced Hybrid Smartwatch
Bruker Launches the Q4 POLO - Compact Spark-OES Metals Analyzer
Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions Says Frost & Sullivan
Bruker Joins PANACEA Network to Broaden Access to NMR for European Chemistry Community
High-end Global Computed Tomography Purchases to Propel the High-end CT Segment Revenue Finds Frost & Sullivan
KRAIBURG TPE Introduces Ergonomically Designed Healthcare Equipment
Fujifilm Lauded by Frost & Sullivan for Disrupting the Operating Room Space with its Systems Integration Solution
BASF’s Irgastab® Enables LOTTE Chemical to Deliver High-clarity Medical Polypropylene for Syringes Used in COVID-19 Vaccinations
Withings and One Drop Partner to Bring Best-in-class Medical Devices to Multi-condition Employer Program

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  The Franchise Group

Visit  Limelon Advertising, Co.

Visit  MONOVERSE USA, Inc.







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today